Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950135-08-008569
Filing Date
2008-12-24
Accepted
2008-12-24 13:27:25
Documents
5
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b73279ipe10vkza.htm 10-K/A 90811
2 EX-10.48 EMPLOYMENT OFFER LETTER DATED NOVEMBER 8, 2007 BY AND BETWEEN IDERA PHA b73279ipexv10w48.htm EX-10.48 43596
3 EX-31.3 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b73279ipexv31w3.htm EX-31.3 2592
4 EX-31.4 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER b73279ipexv31w4.htm EX-31.4 2611
5 GRAPHIC b73279ipb7327900.gif GRAPHIC 7609
  Complete submission text file 0000950135-08-008569.txt   151748
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-31918 | Film No.: 081269968
SIC: 2836 Biological Products, (No Diagnostic Substances)